Warning letterPosted December 23, 2025
FDA warning letter to Revive Rx LLC dba Revive Rx Pharmacy
Compounding Pharmacy/Adulterated Drug Products
FDA posted a warning letter to Revive Rx LLC dba Revive Rx Pharmacy on December 23, 2025; the letter is dated September 22, 2025. Subject: Compounding Pharmacy/Adulterated Drug Products. Issuing office: Center for Drug Evaluation and Research (CDER).
On the record
- Company
- Revive Rx LLC dba Revive Rx Pharmacy
- Subject
- Compounding Pharmacy/Adulterated Drug Products
- Issuing office
- Center for Drug Evaluation and Research (CDER)
- Letter dated
- 2025-09-22
- Posted by FDA
- 2025-12-23
- Source
- FDA warning letters ↗
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Revive Rx LLC dba Revive Rx Pharmacy
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Revive Rx LLC dba Revive Rx Pharmacy.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.